ASCO 2022 Conference Coverage
ASCO 2022 Comparative Effectiveness of Teclistamab vs. Real-World Treatments for Pts With Triple-Class Exposed R/R MM
By
ASCO 2022 Conference Coverage
FEATURING
Amrita Krishnan
By
ASCO 2022 Conference Coverage
FEATURING
Amrita Krishnan
Login to view comments.
Click here to Login
